Yuko Tanaka Osamu Matsubara Kazuhiro Asada Aya Muramatsu Makoto Suzuki Toshihiro Shirai
10.1016/j.rmcr.2019.100885
Respir Med Case Rep
2019 Jun 13;28:100885.
alk, anaplastic lymphoma kinase dic, disseminated intravascular coagulation dvt, deep vein thrombosis ebus-tbna, endobronchial ultrasound-transbronchial needle aspiration ecog, eastern cooperative oncology group egfr, epidermal growth factor receptor hpd, hyperprogressive disease hrct, high-resolution computed tomography hyperprogressive disease ild, interstitial lung disease immune checkpoint inhibitors nsclc, non-small cell lung cancer non-small cell lung cancer pd-l1 pd-l1, programmed cell death ligand 1
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/31249779/
Case Reports
PMC6586950
31249779
Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: An autopsy case study
2019